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Abstract 
Background: Non‑occlusive mesenteric ischemia (NOMI) is a common complication and accounts for a major cause 
of death in critically ill patients. The diagnosis of NOMI with respect to the eventual indications for surgical treatment 
is challenging. We addressed the performance of the diagnostic strategy of NOMI in the intensive care unit, with 
emphasis on contrast‑enhanced abdominal CT‑scan.
Methods: This was a retrospective monocenter study. Patients with clinically suspected acute mesenteric ischemia 
were included if a comprehensive diagnostic workup was carried out including surgical and/or endoscopic digestive 
explorations. Patients with evidence of occlusive mesenteric ischemia were excluded. A definite diagnosis of NOMI 
only relied on surgical or endoscopic findings. Abdominal CT‑scans were reviewed by two radiologists blinded from 
the final diagnosis.
Results: A diagnosis of NOMI could be definitely confirmed or ruled out through surgical or endoscopic explora‑
tions of the digestive tract in 147 patients. With respect to their clinical characteristics, only a history of atrial fibril‑
lation was an independent predictor of NOMI (odds ratio 8.3, 95% confidence interval 2.0–35.2, p = 0.004). Among 
them, 114 patients (75 with and 39 without NOMI) had previously been subjected to contrast‑enhanced abdominal 
CT‑scan. Portal venous gas, pneumatosis intestinalis and, to a lesser extent, abnormal contrast‑induced bowel wall 
enhancement were poorly sensitive, but exhibited good specificities of 95, 85 and 71%, respectively. Nineteen out of 
75 patients (25.3%) without any suggestive radiological signs finally exhibited mesenteric ischemia, including ten with 
intestinal necrosis.
Conclusions: The performance of abdominal CT‑scan for the diagnosis of NOMI is limited. Radiological signs of 
advanced‑stage ischemia are good predictors of definite mesenteric ischemia, while their absence should not be 
considered sufficient to rule out the diagnosis.
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Background
Acute mesenteric ischemia (AMI) is a dreaded complica-
tion in critically ill patients and remains a major diagnos-
tic and therapeutic challenge in most cases. Importantly, 
AMI encompasses two different pathophysiological enti-
ties. Occlusive AMI is caused by the occlusion of large 
mesenteric arteries or veins due to arterial embolism or 
a local thrombotic process. AMI may also occur despite 
preserved patency of large mesenteric vessels, the so-
called non-occlusive mesenteric ischemia (NOMI) [1]. 
NOMI is a common complication in critically ill patients 
with acute circulatory failure and thereby accounts for 
a major cause of death in the intensive care unit (ICU) 
[2, 3]. In a large multicenter study of 780 ICU patients 
with AMI, the overall mortality rate was 58% [4]. None-
theless, surgical treatment within 24  h of diagnosis of 
AMI was identified as an independent predictor of sur-
vival, emphasizing the importance of early and reliable 
diagnosis.
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The diagnosis and the treatment of AMI rely on a 
timely multidisciplinary management involving intensive 
care physicians, gastroenterologists, radiologists and sur-
geons [5]. The diagnosis of AMI is often challenging in 
critically ill patients, most especially for NOMI. It can be 
suspected in the presence of clinical deterioration asso-
ciated with digestive symptoms and biological manifes-
tations suggestive of profound tissue ischemia or acute 
cell lysis. Contrast-enhanced abdominal CT-scan is the 
cornerstone of the diagnostic strategy and may provide 
direct or indirect arguments for impaired vasculariza-
tion of the bowel [6]. However, its accuracy for the diag-
nosis of NOMI in critically ill patients is questionable. A 
confirmatory diagnosis as well as the assessment of the 
extent of necrosis still commonly involves a direct visu-
alization of the digestive tract by endoscopy and/or surgi-
cal exploration.
With respect to the frequent diagnostic uncertainty of 
NOMI in critically ill patients, a better assessment of the 
preoperative probability of mesenteric ischemia as well 
as the eventual possibilities of surgical treatment repre-
sents an important area of improvement in the manage-
ment of the disorder. To this aim, we herein addressed 
the performance of the common diagnostic strategy of 




We performed a retrospective monocenter study over 
an 8-year period (2007–2013) in a 24-bed tertiary medi-
cal ICU. The average number of admissions is 1600 per 
year, and the case-mix is distributed into 90% of medical 
patients and 10% of patients requiring emergency surgery 
at the time of admission or during the stay in the ICU. 
Patients with clinically suspected AMI were included if 
a comprehensive diagnostic workup including surgical 
and/or endoscopic explorations of the digestive tract was 
carried out, regardless of previous abdominal CT-scan 
imaging. Patients with evidence of occlusive AMI (i.e., 
interrupted blood flow in large mesenteric vessels) were 
excluded. This study was part of a project approved by 
the ethics committee of the French Intensive Care Soci-
ety. Informed consent was waived due to the retrospec-
tive observational design of the study.
Intended management of AMI
In our unit, the diagnosis of AMI relies on a multi-
disciplinary approach involving intensive care physi-
cians, gastroenterologists, radiologists and surgeons. 
AMI was commonly suspected on the basis of clinical 
upper or lower digestive symptoms including abdominal 
pain, feeding intolerance, gastrointestinal hemorrhage, 
diarrhea, occlusion, associated or not with deteriora-
tion of organ failures, and biological manifestations of 
tissue ischemia (elevated arterial lactate levels) and cell 
lysis (increased serum levels of lactate dehydrogenase, 
creatine phosphokinase and transaminases). A moder-
ate to high probability for AMI prompted further diges-
tive investigations by contrast-enhanced abdominal 
tomodensitometry and/or upper and lower endoscopic 
explorations and/or laparotomy. Intestinal resection was 
indicated in case of localized bowel necrosis. The major 
steps of patients’ management such as indications for 
major surgery, transfer to the operating room, or deci-
sions of withholding or withdrawing life support were 
discussed collectively.
Diagnostic criteria of acute mesenteric ischemia
Two radiologists (AO and HG) blinded from the final 
diagnosis reviewed all abdominal CT-scans. Multidetec-
tor CT-scan were first carried out without contrast and 
secondarily contrast-enhanced with early (arterial time 
30  s) and delayed (portal venous time 60–70  s) acquisi-
tions following intravenous contrast medium infusion. 
The following radiological signs were systematically col-
lected: pneumatosis intestinalis defined by the presence 
of gas inside the bowel’s walls, bowel dilatation, portal 
venous gas, aortic or mesenteric atherosclerosis, lack or 
heterogeneity of contrast-induced enhancement of bow-
el’s walls (Fig. 1). All eventual operative and endoscopic 
report forms were reviewed by investigators (GG and SL) 
blinded from the CT-scan findings. Regardless of CT-
scan, only undisputed mesenteric ischemia diagnosed 
by surgical or endoscopic explorations were classified as 
definite NOMI. Extensive ischemia was defined as diges-
tive ischemia involving more than one digestive segment. 
Conversely, NOMI was ruled out when neither surgical 
nor endoscopic explorations retrieved macroscopic evi-
dence of digestive ischemia.
Collection of data
The following data were collected, either extracted from 
our patient’s data management system (Centricity Clin-
iSoft, GE Healthcare) or retrieved from individual medi-
cal files: demographics (age and gender), underlying 
comorbidities including cardiovascular diseases, the pri-
mary diagnosis warranting ICU admission, the severity of 
illness at the time of ICU admission as assessed by the 
Simplified Acute Physiology Score II (SAPS II) and the 
Sequential Organ Failure Assessment (SOFA) scores [7, 
8]. Features associated with clinically suspected NOMI 
were the following: time from admission to clinical suspi-
cion (i.e., to the first digestive exploration, CT-scan, sur-
gery or endoscopy), digestive symptoms, arterial blood 
lactate, serum enzymes levels (lactate dehydrogenase, 
Page 3 of 8Bourcier et al. Ann. Intensive Care  (2016) 6:112 
creatine phosphokinase, transaminases), concurrent 
organ failures as quantified by the SOFA score.
Statistical analysis
Statistical analyses were performed using the software 
Prism 5.0 (Graphpad, San Diego, CA). Categorical data 
are presented as numbers (%) and compared by Chi-
square or Fisher’s exact test as appropriate. Continuous 
variables are expressed as median and interquartile range 
and compared using the nonparametric Mann–Whit-
ney test. Variables found associated with a p value <0.20 
in univariate analysis were entered into a multivariate 
backward stepwise logistic regression analysis in order 
to identify the factors independently associated with a 
definite diagnosis of NOMI. The goodness-of-fit of the 
model was checked by the Hosmer–Lemeshow test.
Results
AMI was suspected in 230 patients on the basis of clini-
cal and biological manifestations and prompted some 
specific digestive investigations. Most patients (197/230, 
85%) were explored by contrast-enhanced abdomi-
nal CT-scan and were secondarily subjected to further 
digestive explorations by surgery (n  =  93 including 10 
patients who also had digestive endoscopy) or by endos-
copy only (n =  21) (Fig.  2). Of note, nine patients were 
excluded because the CT-scan displayed evidence of 
occlusive AMI with interrupted blood flow within the 
upper mesenteric artery. The characteristics of the 83 
patients who had CT-scan without further exploration 
are shown in the Additional file 1: Table S1. Thirty-three 
patients did not have CT-scan and were directly investi-
gated by surgery (n = 11 including two patients who also 
had digestive endoscopy) or by endoscopy only (n = 22). 
Altogether, surgery and digestive endoscopy led to a 
definite diagnosis of NOMI in 92 patients (70 and 22 
patients, respectively) and ruled it out in 55 patients.
The characteristics of patients with and without NOMI 
are displayed in Table 1. NOMI was mostly ICU-acquired 
since diagnosed at 3.9 (1.5–12.9) days from ICU admis-
sion. Patients with definite NOMI were older and were 
less likely to have diabetes and more likely to have atrial 
fibrillation. The primary causes for ICU admission as 
well as the initial severity of illness were similar. Clinical 
symptoms and biological manifestations hardly discrimi-
nated the patients with definite NOMI from those for 
Fig. 1 Representative CT‑scan findings of non‑occlusive mesenteric ischemia. a Absence of contrast‑induced bowel wall enhancement (arrows). b 
Pneumatosis intestinalis and absence of contrast‑induced bowel wall enhancement (arrows). c Bowel dilatation and absence of contrast‑induced 
bowel wall enhancement (arrows). d Portal venous gas (arrows)
Page 4 of 8Bourcier et al. Ann. Intensive Care  (2016) 6:112 
whom NOMI could be ruled out. In a multivariate logis-
tic regression analysis adjusted with the other factors 
(age, gender, diabetes, body mass index, creatine phos-
phokinase level, concurrent antibiotic treatment) that 
reached a p value <0.2 in the univariate analysis (Table 1), 
only a history of atrial fibrillation was an independ-
ent predictor of NOMI (odds ratio 8.3, 95% confidence 
interval 2.0–35.2, p  =  0.004). The Hosmer–Lemeshow 
goodness-of-fit assessment of the final model reported a 
p value of 0.90.
Intestinal necrosis was the main macroscopic aspect 
observed during laparotomy (77.1% of patients) (Table 2). 
Ischemia could be located to every intestinal segment 
and involved more than one segment in 37.1% of cases. A 
surgical treatment by segmental intestinal resection was 
possible for 47 patients (67.5% of operated patients). A 
definite diagnosis of NOMI was associated with a poor 
prognosis with an in-ICU mortality rate of 76%.
With respect to the challenging diagnosis of NOMI in 
this setting, we addressed the diagnostic performance of 
abdominal CT-scan in the 114 patients who were sub-
jected to both contrast-enhanced abdominal CT-scan 
and one of the reference investigations, either surgery or 
digestive endoscopy (Fig.  2). Among them, NOMI was 
definitely confirmed or ruled out in 75 and 39 patients, 
respectively. The individual assessments of radiological 
signs are presented in Table 3 and in the Additional file 1: 
Table S2. Aortic or mesenteric atherosclerosis was pre-
sent in most patients and thereby had very good sensitiv-
ity, but poor specificity. Portal venous gas, pneumatosis 
intestinalis and, to a lesser extent, abnormal contrast-
induced bowel wall enhancement were poorly sensitive, 
but exhibited good specificities of 95, 85 and 71%, respec-
tively. These three radiological signs were often com-
bined in patients with NOMI (Additional file  1: Figure 
S1). Of note, 19 out of 75 patients (25.3%) without any 
suggestive radiological signs finally exhibited mesenteric 
ischemia (13 diagnosed by surgery and 6 by endoscopy), 
resulting in intestinal necrosis in ten patients.
Discussion
AMI encompasses two different pathophysiological 
entities affected with distinct diagnostic and therapeu-
tic issues. The diagnosis of occlusive AMI is often obvi-
ous, relying on the blockage of blood flow within large 
mesenteric arteries or veins on a contrast-enhanced 
CT-scan. The treatment combines surgical or instru-
mental arterial reperfusion and the eventual resection 
of necrotic bowel segments [9, 10]. In contrast, NOMI 
occurs despite seemingly preserved mesenteric blood 
flow and is most often associated with advanced age, 
cardiac insufficiency, atrial fibrillation, hemodialysis 
and prior episodes of hypotension [11–14]. It represents 
a significant complication in critically ill patients with 
severe and prolonged acute circulatory failure [2, 3]. 
However, prolonged hypoperfusion does not recapitulate 
the mechanisms that contribute to the advent of NOMI, 
that also involves mesenteric vasoconstriction, intestinal 
hypoxia while increased intestinal metabolic demand, 
ischemia–reperfusion injury, apoptosis and decreased 
proliferation of enterocytes [15]. Tissue necrosis and dis-
ruption of the intestinal barrier may then result in bacte-
rial translocation, systemic inflammatory response and 
multiple organ failure [11].
Fig. 2 Investigations for acute mesenteric ischemia. a Flowchart of the study. Including 2 (*) and 10 (**) patients for whom both laparotomy and 
endoscopy were performed. b Distribution of diagnostic procedures. AMI acute mesenteric ischemia, NOMI non‑occlusive mesenteric ischemia
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Regardless of the underlying ischemic process, occlu-
sive or non-occlusive, the prognosis of AMI is poor as the 
overall mortality rate may reach 80% in most published 
cohorts [3, 16–18]. Leone and colleagues provided relia-
ble prognostic data for AMI in an impressive multicenter 
series of 780 cases [4]. The in-ICU mortality rate was 
58%, and the possibility of an initial surgical treatment 
was identified as an independent predictor of survival. 
However, an important limit of the paper lies in the 
absence of formal diagnostic criteria for AMI. Indeed, the 
Table 1 Characteristics of patients with and without non-occlusive mesenteric ischemia
Characteristics Definite NOMI (n = 92) NOMI ruled out (n = 55) p
Baseline characteristics
 Age (years) 75 (61–81) 66 (55–78) 0.02
 Male gender 41 (45%) 31 (56%) 0.18
 BMI (kg/m2) 24 (21–27) 26 (23–29) 0.15
 Comorbidities
  Diabetes 13 (14%) 16 (29%) 0.03
  Hypertension 50 (54%) 27 (49%) 0.61
  Smoking 43 (47%) 26 (47%) 1.0
  Coronary disease 26 (28%) 20 (36%) 0.36
  Peripheral vascular disease 14 (15%) 12 (22%) 0.37
  End‑stage renal disease 7 (8%) 4 (7%) 1.0
  Atrial fibrillation 33 (36%) 12 (22%) 0.10
 Main diagnosis at ICU admission 0.90
  Severe sepsis or septic shock 41 (45%) 22 (40%)
  Cardiogenic shock 3 (3%) 4 (7%)
  Hypovolemic shock 14 (15%) 7 (13%)
  Hemorrhagic shock 9 (10%) 7 (13%)
  Acute kidney injury 3 (3%) 3 (5%)
  Cardiac arrest 13 (14%) 7 (13%)
  Cardiac surgery 9 (10%) 5 (9%)
 Illness severity at admission (points)
  SAPS II 70 (57–87) 74 (48–91) 0.75
  SOFA 8 (5–11) 8 (4–12) 0.78
Diagnosis of NOMI
 Time to diagnosis (days)a 3.9 (1.5–13.0) 4.7 (2.1–9.7) 0.68
 Concurrent anticoagulation 0.75
  Preventive 34 (37%) 17 (31%)
  Curative 19 (20.7%) 13 (23.6%)
 Concurrent antibiotic treatment 90 (97.8%) 46 (83.6%) 0.002
 SOFA (points) 10 (6–13) 9 (7–12) 0.97
 Clinical manifestations
  Lower digestive symptoms 56 (61%) 29 (53%) 0.39
  Upper digestive symptoms 38 (41%) 19 (35%) 0.49
 Bacteremia 20 (21.7%) 9 (16.4%) 0.43
 Serum laboratory results
  Bicarbonates (mmol/L) 16.0 (14.0–21.1) 17.0 (14.5–21.5) 0.83
  Arterial lactate (mmol/L) 5.6 (2.2–10.1) 6.3 (2.1–11.2) 0.60
  Creatinine (μmol/L) 159 (125–231) 132 (84–247) 0.29
  K+ (mmol/L) 4.6 (4.1–5.4) 4.5 (3.9–5.2) 0.46
  CPK, ×UNV 1.0 (0.4–5.6) 3.0 (7.8–9.1) 0.09
  LDH, ×UNV 4.9 (2.2–12.7) 7.5 (2.8–17.3) 0.35
  AST, ×UNV 7.8 (1.3–43.7) 3.0 (1.0–43.5) 0.30
  Leukocyte count (G/L) 14.1 (9.5–23.6) 15.3 (8–22.5) 0.96
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diagnosis of AMI could be supported by gastrointestinal 
endoscopy or surgery, or alternatively by CT-scan only in 
the majority (58%) of patients. Furthermore, the mecha-
nism of mesenteric ischemia, occlusive versus non-occlu-
sive, was not reported either.
Despite a better awareness of the disorder, the diagno-
sis of NOMI remains particularly challenging in critically 
ill patients, and diagnostic uncertainty may ultimately 
require surgical explorations for an accurate assess-
ment of the bowel. Every effort should be made to refine 
the diagnostic performance for AMI, in order to avoid 
unnecessary and aggressive surgical interventions in 
patients without digestive ischemia, and also in patients 
with end-stage extensive necrosis ineligible for segmen-
tal intestinal resection. We herein assessed a stringent 
diagnostic workup in which AMI could only be defi-
nitely confirmed or ruled out by direct visualization of 
the digestive tract by endoscopic or surgical explorations. 
We addressed the performance of the main diagnostic 
steps including clinical and biological manifestations and 
abdominal CT-scan. Clinical symptoms and biological 
markers of tissue ischemia and acute cell lysis may com-
monly suggest the diagnosis of mesenteric ischemia, but 
clearly lack sensitivity and specificity in this setting [19, 
20]. More relevant information is expected from abdomi-
nal CT-scan [6].
The performance of CT-scan has been reported as good 
to excellent in the diagnosis of AMI with sensitivity and 
specificity, generally about 90% [6]. However, it should 
be emphasized that these studies were performed in the 
setting of occlusive AMI, in which the diagnosis is made 
much easier by the blockade of mesenteric blood flow. In 
contrast, few studies have addressed its diagnostic value 
in NOMI. We report here that abdominal CT-scan has 
limited performance in this setting. Portal venous gas or 
pneumatosis intestinalis appeared as specific radiologi-
cal signs (specificities 95 and 85%, respectively). None-
theless, both may be seen in non-ischemic conditions 
including connective tissue disorders, inflammatory 
bowel diseases, cytotoxic chemotherapy and major bowel 
distension [21]. Abnormal wall enhancement was associ-
ated with a lower but still reasonable specificity of 71%. 
However, a major limit of those three CT-scan signs lied 
in their poor sensitivity (19, 32 and 62%, respectively), 
making their diagnostic contribution irrelevant in most 
patients.
Which clinical implications can be drawn from our 
findings? Although we pointed out the limitations of 
CT-scan, we keep thinking that it should remain the cor-
nerstone of the diagnostic workup of AMI in the ICU. 
However, only a surgical exploration is currently able to 
Table 1 continued
Characteristics Definite NOMI (n = 92) NOMI ruled out (n = 55) p
  Hemoglobin (g/dL) 10.0 (8.9–11.3) 9.9 (8.9–11.2) 0.51
  Platelets (G/L) 120 (61–199) 117 (62–182) 0.94
ICU mortality 69 (76%) 27 (49%) 0.002
Categorical variables are expressed as median (interquartile range)
Lower digestive symptoms include hematochezia, melena and diarrhea. Upper digestive symptoms include vomiting, feeding intolerance and acute upper 
gastrointestinal bleeding
BMI body mass index, NOMI non-occlusive mesenteric ischemia, ICU intensive care unit, SAPS II simplified acute physiology score II, SOFA sequential organ failure 
assessment, UNV upper normal value (IU/L)
a Time from ICU admission to the first investigation of NOMI (CT-scan, surgery or endoscopy)




 Stomach and/or duodenum 30 (32.6)
 Jejunum and/or ileum 44 (47.8)
 Right colon 50 (54.3)
 Left colon 46 (50)
 Sigmoid colon 39 (42.4)
 Rectum 12 (13)
Surgical findings 70 (100)
 Peritonitis 15 (21.4)
 Perforation 14 (20)
 Peritoneal effusion 48 (68.6)
 Necrosis 54 (77.1)
 Non‑necrotic ischemic lesions 16 (22.9)
 Extent of ischemia
 Extensive (≥2 intestinal segments) 28 (40)
 Segmental 42 (60)
Digestive endoscopy 29 (100)
 Upper digestive fibroscopy 12 (41.4)
 Colonoscopy 12 (41.4)
 Rectosigmoidoscopy 5 (17.2)
Endoscopic findings 29 (100)
 Ischemia 19 (65.5)
 Necrosis 10 (34.5)
Page 7 of 8Bourcier et al. Ann. Intensive Care  (2016) 6:112 
provide an accurate assessment of bowel viability and 
to delineate the frankly necrotic sections requiring seg-
mental intestinal resection. On the other hand, partially 
ischemic bowel regions might be liable to salvage after 
intraoperative visualization of restored mesenteric per-
fusion, spontaneously or after injection of a fluorescent 
dye [22]. The presence of portal venous gas or pneuma-
tosis intestinalis surely indicates urgent exploratory lapa-
rotomy. The same should probably apply to abnormal 
wall enhancement. Finally, the still unanswered question 
remains about surgical indications in patients with nega-
tive abdominal imaging. Although it is difficult to provide 
firm recommendations, we would then propose a prag-
matic approach in which surgical indications should be 
based on eventual clinical deterioration despite optimal 
medical treatment and advanced organ failure supports.
Finally, the most important treatment for NOMI is 
preventive and every effort should be made to limit 
the duration and severity of acute circulatory failure. 
Our therapeutic goals in this setting still remain largely 
based on macroscopic circulatory parameters, whereas 
microcirculatory disorders may also contribute to organ 
failures in an independent manner [23]. Reliable assess-
ment of microcirculatory tissue perfusion in critically 
ill patients has been made possible by technological 
advances. However, the therapeutic implications remain 
questionable [24].
Our study has strengths and limitations that deserve to 
be mentioned. Its main strength lies in its stringent meth-
odology despite its retrospective design. A definite diag-
nosis or conversely elimination of mesenteric ischemia 
required confirmatory investigations by surgery and/
or endoscopy and could only be presumed on CT-scan. 
Furthermore, the investigators who interpreted the CT-
scan imaging and those who confirmed the diagnosis of 
mesenteric ischemia through endoscopic and surgical 
reports were different and kept blinded from other con-
current investigations. With respect to limitations, this 
was a single-center study performed in a medical ICU set-
ting where the large majority of patients are referred for a 
wide range of medical conditions. The retrospective design 
of the study may have led to incomplete identification of 
patients with suspected mesenteric ischemia. This is the 
reason why we only included patients with a significant 
clinical probability of AMI who were therefore explored 
by an abdominal CT-scan, or directly by endoscopy or sur-
gery. In addition, urgent endoscopy can only explore the 
upper (oesophagus, stomach and duodenum) and lower 
(rectum and colon) extremities of the digestive tract, leav-
ing unexplored the jejunum and ileum in between. We 
cannot exclude that some patients only explored by endos-
copy without further surgery may still display mesenteric 
ischemia in non-visualized intestinal regions.
Conclusions
AMI remains a diagnostic and therapeutic challenge 
in critically ill patients, especially in case of non-occlu-
sive forms. The diagnostic contribution of abdominal 
CT-scan is limited in this setting. Radiological signs of 
advanced-stage ischemia represent undisputed indica-
tions for surgical intervention to assess the extent of 
bowel necrosis and the possibility of intestinal resection. 
The absence of radiological signs suggesting mesenteric 
ischemia should not be considered sufficient to rule out 
the diagnosis and still warrants further digestive explo-
rations by endoscopy and/or laparotomy in case of high 
clinical suspicion.
Additional file
Additional file 1: Figure S1. Distribution of radiological signs in patients 
with definite non‑occlusive mesenteric ischemia. The Venn’s diagram 
was drawn from the 48 patients with definite non‑occlusive mesenteric 
ischemia displaying at least one of the three most specific radiological 
signs. Table S1. Characteristics of patients who had CT‑scan without fur‑
ther explorations. Table S2. Determinants of abnormal radiological signs 
in patients with definite non‑occlusive mesenteric ischemia (n = 75).
Table 3 Performance of abdominal CT-scan findings in the diagnosis of non-occlusive mesenteric ischemia
Values in brackets represent the 95% confidence interval
NOMI non-occlusive mesenteric ischemia, NPV negative predictive value, PPV positive predictive value




Odds ratio p Sensitivity % Specificity % PPV % NPV %
Abnormal wall 
enhancement
62.0 28.6 4.07 (1.70–9.78) <0.001 62 (50–73) 71 (54–85) 81 (69–91) 48 (34–62)
Pneumatosis intes‑
tinalis
32.4 15.4 2.64 (0.97–7.16) 0.07 32 (22–44) 85 (69–94) 80 (61–92) 40 (29–51)
Bowel dilatation 62.2 56.4 1.27 (0.58–2.79) 0.69 62 (50–73) 44 (28–60) 68 (55–78) 38 (24–53)
Portal venous gas 18.9 5.1 4.32 (0.93–20.09) 0.05 19 (11–30) 95 (83–99) 88 (62–98) 38 (28–49)
Atherosclerosis 90.6 82.0 2.09 (0.68–6.48) 0.23 91 (81–96) 18 (8–34) 68 (58–77) 50 (23–77)
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